RSS   Newsletter   Contact   Advertise with us
Post Online Media

Bristol-Myers Squibb appoints Giovanni Caforio as chairman

Giovanni CaforioBristol-Myers Squibb Company announced that it has appointed Giovanni Caforio as chairman of the board from May 2, 2016.
Article continues below

READ MORE Bristol-Myers Squibb names Giovanni Caforio COO and to board

Mr. Caforio has been chief executive officer of Bristol-Myers Squibb since May 2015 and has been serving on the company’s Board of Directors since June 2014.

Prior to becoming CEO, Mr. Caforio served as chief operating officer with responsibility for leading a fully integrated worldwide commercial organization and the companywide functions of Enterprise Services and Global Manufacturing & Supply.

This was preceded by his work as the company’s chief commercial officer.

Mr. Caforio received his M.D. from the University of Rome.

Mr. Caforio, who will continue to serve as chief executive officer, will succeed current Chairman Lamberto Andreotti, who has announced his plan to retire.

Mr. Andreotti served as Bristol-Myers Squibb’s chief executive officer from 2010 through May 2015 and will have served as Bristol-Myers Squibb’s chairman for two years when Caforio’s appointment becomes effective in May 2017.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy